11/3/2003

Ampakines, a new type of drug being developed by Cortex Pharmaceuticals, could hold promise for the treatment and prevention of Alzheimer's disease and other deteriorations in memory. The drugs work by boosting glutamate, a chemical that helps transmit electrical signals between brain cells.

Related Summaries